or Try an Advanced Search...

    Technical Analysis for IMNM - Immunome, Inc.

    Grade Last Price % Change Price Change
    F 12.18 0.66% 0.08
    IMNM closed up 0.83 percent on Monday, July 1, 2024, on 83 percent of normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
    2 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical IMNM trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction -0.16%
    Wide Bands Range Expansion -0.16%
    Oversold Stochastic Weakness -0.16%
    Pocket Pivot Bullish Swing Setup 0.66%
    Volume Surge Other 0.66%
    Wide Bands Range Expansion 0.66%
    Oversold Stochastic Weakness 0.66%
    180 Bearish Setup Bearish Swing Setup 1.75%
    Slingshot Bearish Bearish Swing Setup 1.75%
    NR7 Range Contraction 1.75%
    Older End-of-Day Signals for IMNM ...

       Recent Intraday Alerts

    Alert Time
    Possible NR7 about 6 hours ago
    Rose Above Previous Day's High about 10 hours ago
    Up 1% about 10 hours ago
    Down 2 % about 10 hours ago
    Down 1% about 10 hours ago
    View Earlier Intraday Alerts

    Get this analysis on your stocks daily!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Read My Charts!
    Configure default chart indicators
    IMNM Chart by TradingView
    Basic chart:

    Profile

    Immunome Inc., a biotechnology company, discovers, develops, and commercializes highly targeted and native human cancer antibodies against universal cancer antigens. Its RealMAb technology enables the discovery of novel antigens and the cognate native human antibodies that target antigens; and ScreenMab multiplex functional screening technology identifies monoclonal antibodies that have exquisite for tumor neoantigens. The company was founded in 2006 and is based in Exton, Pennsylvania.
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Medicine Biotechnology Clinical Medicine Immunology Immune System Antibodies Tumor Cancer Immunotherapy Monoclonal Antibodies Monoclonal Antibody Antibody Glycoproteins Antigen Symphogen

    Is IMNM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Jun 27 Immunome: AL102 And Other Established Protein Targets Could Drive Value
    Jun 27 Immunome: Enthusiasm For New Management Has Faded
    Jun 27 Immunome names Tsai as chief technical officer
    Jun 27 Immunome Appoints Phil Tsai as Chief Technical Officer
    May 31 Evaluating Immunome: Insights From 4 Financial Analysts
    May 22 Over $13M Bet On ProFrac Holding? Check Out These 4 Stocks Insiders Are Buying
    May 21 Insider Buying: Immunome Inc's CEO Acquires 100,000 Shares
    May 20 Immunome Announces Completion of Purchase of Assets from Atreca
    May 17 Immunome appoints CFO
    May 17 Immunome Announces Promotion of Max Rosett to Chief Financial Officer
    See more IMNM news...

    Comments

    T

    TraderMike 5 months ago

    I was in the right place at the right time on this today. 🎉  I actually bought it yesterday after it made a (you guessed it) 
    Non-ADX 1,2,3,4 Bullish     signal the day before.  I sold half around 21 and am still holding the other half of the shares.  

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 30.958
    52 Week Low 6.13
    Average Volume 1,107,346
    200-Day Moving Average 14.24
    50-Day Moving Average 14.35
    20-Day Moving Average 13.83
    10-Day Moving Average 12.32
    Average True Range 0.92
    RSI (14) 35.48
    ADX 23.92
    +DI 15.56
    -DI 30.46
    Chandelier Exit (Long, 3 ATRs) 14.00
    Chandelier Exit (Short, 3 ATRs) 13.83
    Upper Bollinger Bands 17.05
    Lower Bollinger Band 10.61
    Percent B (%b) 0.25
    BandWidth 46.59
    MACD Line -0.91
    MACD Signal Line -0.75
    MACD Histogram -0.1633
    Fundamentals Value
    Market Cap 549.35 Million
    Num Shares 45 Million
    EPS -1.80
    Price-to-Earnings (P/E) Ratio -6.78
    Price-to-Sales 105.68
    Price-to-Book 174.08
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 12.93
    Resistance 3 (R3) 12.88 12.58 12.81
    Resistance 2 (R2) 12.58 12.39 12.61 12.77
    Resistance 1 (R1) 12.39 12.28 12.48 12.44 12.73
    Pivot Point 12.09 12.09 12.14 12.12 12.09
    Support 1 (S1) 11.90 11.90 12.00 11.96 11.67
    Support 2 (S2) 11.60 11.79 11.63 11.63
    Support 3 (S3) 11.41 11.60 11.59
    Support 4 (S4) 11.47